These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7539806)

  • 1. The use of high doses of aprotinin to decrease blood loss in aortocoronary by-pass surgery.
    Dementieva II; Dzemeshkevich SL; Charnaya MA; Shabalkin BV
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):185-6. PubMed ID: 7539806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of high doses of aprotinin on intra- and postoperative blood loss in surgery with artificial circulation].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1995; (2):91-3. PubMed ID: 7544074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The preventive role of large doses of aprotinin in decreasing the degree of metabolic disorders during aortocoronary bypass operations].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Ziuliaeva TP
    Anesteziol Reanimatol; 1996; (1):55-8. PubMed ID: 8686945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG
    Vestn Khir Im I I Grek; 2005; 164(6):69-73. PubMed ID: 16792320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood.
    Havel M; Grabenwöger F; Schneider J; Laufer G; Wollenek G; Owen A; Simon P; Teufelsbauer H; Wolner E
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):807-10. PubMed ID: 7510351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction of per- and postoperative blood loss with aprotinin (Trasylol) during extracorporeal circulation].
    Deleuze P; Loisance DY; Feliz A; Hillion ML; Castanié JB; Richemond J; Cachera JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84(12):1797-802. PubMed ID: 1724365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of high doses of aprotinin in cardiac surgery].
    Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A
    Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of a combined administration of different doses of aprotinin and autologous blood transfusions for coagulation and fluid replacement in cardiac surgery.
    Gschossmann J; Pracki P; Vicol C; Struck E
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):187-8. PubMed ID: 7539807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of "low dose" aprotinin in open heart surgery and its plasma concentration].
    Nakamura T; Shimamoto M; Yamazaki F; Fujita S; Yoshimura T; Ueno T; Oyanagi H; Shinozaki T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Feb; 42(2):188-93. PubMed ID: 7511150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of high-dose aprotinin to stabilize hemostasis in artificial circulation].
    Dement'eva II; Piatnitskaia GKh; Dzemeshkevich SL; Charnaia MA
    Anesteziol Reanimatol; 1993; (1):66-70. PubMed ID: 7524380
    [No Abstract]   [Full Text] [Related]  

  • 16. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated clotting time, anticoagulation, use of heparin, and thrombin activation during extracorporeal circulation: changes under aprotinin therapy.
    Feindt P; Volkmer I; Seyfert U; Huwer H; Kalweit G; Gams E
    Thorac Cardiovasc Surg; 1993 Feb; 41(1):9-15. PubMed ID: 7690165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of aprotinin for hemostasis during intracranial surgery.
    Palmer JD; Francis JL; Pickard JD; Iannotti F
    J Neurosurg; 2003 Jun; 98(6):1208-16. PubMed ID: 12816266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.